243 related articles for article (PubMed ID: 10068356)
21. Guidelines for the management of patients with chronic stable angina: treatment.
Fihn SD; Williams SV; Daley J; Gibbons RJ; ; ;
Ann Intern Med; 2001 Oct; 135(8 Pt 1):616-32. PubMed ID: 11601935
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
[TBL] [Abstract][Full Text] [Related]
23. Intensity of antianginal therapy in patients referred for coronary angiography: a comparison of fee-for-service and health maintenance organization therapeutic strategies.
Samuels BA; Diamond GA; Mahrer PR; Denton TA
Clin Cardiol; 2000 Mar; 23(3):165-70. PubMed ID: 10761803
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of silent ischemia].
Mlczoch J
Acta Med Austriaca; 1992; 19(3):70-3. PubMed ID: 1357905
[TBL] [Abstract][Full Text] [Related]
25. Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry.
Venkitachalam L; Kip KE; Mulukutla SR; Selzer F; Laskey W; Slater J; Cohen HA; Wilensky RL; Williams DO; Marroquin OC; Sutton-Tyrrell K; Bunker CH; Kelsey SF;
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):607-15. PubMed ID: 20031899
[TBL] [Abstract][Full Text] [Related]
26. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
JAMA; 1997 Mar; 277(9):715-21. PubMed ID: 9042843
[TBL] [Abstract][Full Text] [Related]
27. [Drug treatment of unstable angina pectoris using nitrates, beta blockers and calcium antagonists].
Erne P
Praxis (Bern 1994); 1995 Feb; 84(6):176-80. PubMed ID: 7871302
[TBL] [Abstract][Full Text] [Related]
28. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.
Henderson RA; Pocock SJ; Clayton TC; Knight R; Fox KA; Julian DG; Chamberlain DA;
J Am Coll Cardiol; 2003 Oct; 42(7):1161-70. PubMed ID: 14522473
[TBL] [Abstract][Full Text] [Related]
29. The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention.
Qintar M; Towheed A; Tang F; Salisbury AC; Ho PM; Grantham JA; Spertus JA; Arnold SV
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054844
[TBL] [Abstract][Full Text] [Related]
30. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
31. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators.
Eisenberg MJ; Califf RM; Cohen EA; Adelman AG; Mark DB; Topol EJ
Am J Cardiol; 1997 Apr; 79(7):867-72. PubMed ID: 9104896
[TBL] [Abstract][Full Text] [Related]
32. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
Aronow WS
Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
34. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine.
Hartigan PM; Giacomini JC; Folland ED; Parisi AF
Am J Cardiol; 1998 Dec; 82(12):1445-50. PubMed ID: 9874045
[TBL] [Abstract][Full Text] [Related]
35. [Angina pectoris--preliminary stage to a myocardial infarct].
Mertens HM
Dtsch Krankenpflegez; 1991 Feb; 44(2):82-5. PubMed ID: 1672272
[No Abstract] [Full Text] [Related]
36. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
[TBL] [Abstract][Full Text] [Related]
37. Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelines.
Cannon CP; Waheed S
Rev Cardiovasc Med; 2009; 10 Suppl 1():S21-9. PubMed ID: 19898284
[TBL] [Abstract][Full Text] [Related]
38. Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.
Shen L; Vavalle JP; Broderick S; Shaw LK; Douglas PS
Clin Cardiol; 2016 Dec; 39(12):721-727. PubMed ID: 28026916
[TBL] [Abstract][Full Text] [Related]
39. Drugs, angioplasty nearly equal for angina relief.
Harv Heart Lett; 2008 Nov; 19(3):7. PubMed ID: 19024777
[No Abstract] [Full Text] [Related]
40. Effect of antianginal medications on the prognostic value of exercise thallium scintigraphy.
Burns RJ; Kruzyk GC; Armitage DL; Druck MN
Can J Cardiol; 1989; 5(1):29-32. PubMed ID: 2563954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
